A mbulatory blood pressure (BP) monitoring (ABPM) complements clinic BP by obtaining out-of-clinic BP measurements, typically during a 24-hour period.
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were independent of clinic BP and observed for both participants with prehypertension and normal clinic BP.
Methods

Study Population
The JHS is a population-based prospective cohort study, which was designed to evaluate cardiovascular disease risk among blacks. 18, 19 The JHS enrolled 5301 noninstitutionalized blacks, aged ≥21 years, between 2000 and 2004 from the Atherosclerosis Risk in the Community site in Jackson, MS, and a representative sample of urban and rural Jackson, MS, metropolitan tricounty (Hinds, Madison, and Rankin counties) residents, volunteers, randomly selected individuals, and secondary family members. 20 The current analysis was restricted to 1148 JHS participants who completed ABPM after the baseline study visit (visit 1). Participants who did not meet the International Database on ABPM in relation to Cardiovascular Outcomes 21 (IDACO) criteria for valid ABPM (n=102; described below), or who were missing clinic BP or information on antihypertensive medication use at the baseline visit (n=63) were excluded. Participants whose incident clinic hypertension status could not be determined, including those who did not attend visit 2 (2005-2008) and visit 3 (2009-2012) (n=82) or with missing information on BP or antihypertensive medication use at both of these visits (n=10) were also excluded as their incident clinic hypertension status could not be determined. For the current analysis, we further excluded participants with clinic systolic BP (SBP) ≥140 mm Hg or diastolic BP (DBP) ≥90 mm Hg or who were on antihypertensive medication during the baseline visit (n=574), leaving 317 participants for the current analysis. The JHS was approved by the institutional review boards of the University of Mississippi Medical Center, Jackson State University, and Tougaloo College. The institutional review boards at Columbia University and University of Alabama at Birmingham approved the use of JHS data for the current analysis. All participants provided written informed consent.
Data Collection and Clinical Covariates
Detailed description of data collection, methodology, specimen collection, and specimen processing from the baseline visit (visit 1) can be found in the online-only Data Supplement (Methods section in the online-only Data Supplement) and have been previously described. 19, 22 Briefly, data were collected at baseline during an inhome interview, clinic examination, and ABPM. During the clinic examination, trained technicians measured height, weight and BP, collected blood samples, and conducted 2-dimensional echocardiography. Antihypertensive medication use was defined by self-report. Clinic BP was measured after standardized procedures as described below. Left ventricular mass and left ventricular mass index (LVMI) were derived according to American Society of Echocardiography recommendations. 23 Left ventricular hypertrophy (LVH) was defined as LVMI ≥96 g/m 2 in females and LVMI ≥116 g/m 2 in males. After the clinical examination, participants completed ABPM.
Clinic BP Measurement
At each visit, participants rested for at least 5 minutes in an upright position with their back and arms supported, feet flat on the floor and legs uncrossed before having their BP measured. Trained staff conducted 2 BP measurements in the right arm. One minute elapsed between the 2 measurements. An appropriate cuff size, determined from an arm circumference measurement, was used. The JHS Coordinating Center conducted quality control by monitoring digit preference for each technician and by comparing mean BP measurements within and between trained technicians. The 2 clinic-measured BP measurements were averaged for analysis.
Clinic BP was measured using a random-zero sphygmomanometer (Hawksley and Sons Ltd, Lancing, United Kingdom) at visits 1 and 2 and a semiautomatic oscillometric device (Omron HEM-907XL, Omron Healthcare Inc, Lake Forest, IL) at visit 3. Among the 4182 JHS participants who attended visit 2 and had clinic BP measurement, 2115 were included in a BP comparability substudy for which BP was assessed simultaneously, using a Y connector, by randomzero sphygmomanometer and the Omron HEM-907XL device. As described in the Methods section in the online-only Data Supplement, the random-zero BP measurements were calibrated to the semiautomated device using robust regression. When available, clinic BP from the semiautomated device was used. In the current analysis, the calibrated BP measurements were used at visit 1 for the 317 participants and at visit 2 for 206 participants who did not have their BP measured using the semiautomatic oscillometric device.
Incident clinic hypertension was defined as the first follow-up study visit (visits 2 or 3) with clinic SBP ≥140 mm Hg, DBP ≥90 mm Hg, or antihypertensive medication use.
Ambulatory Blood Pressure Monitoring
Immediately after the baseline examination, participants were fitted with an ABPM device (Spacelabs 90207, Spacelabs, Redmond, WA) on their nondominant arm. Ambulatory BP was recorded every 20 minutes. After 24 hours, the device was removed, and data were downloaded onto a computer and processed with Medifacts International's Medicom software (Rockville, MD). IDACO criteria were used to define whether the ABPM measurement was complete. Specifically, participants were considered to have a complete ABPM if they had ≥10 daytime (10 am-8 pm) and ≥5 night-time (12 am-6 am) SBP and DBP measurements. 21 Mean daytime SBP and DBP, mean night-time SBP and DBP, and mean 24-hour SBP and DBP were calculated by averaging the readings during the daytime, night-time, and the entire ABPM period, respectively.
Daytime hypertension was defined as mean daytime SBP ≥135 mm Hg or mean daytime DBP ≥85 mm Hg, night-time hypertension was defined as mean night-time SBP ≥120 mm Hg or mean night-time DBP ≥70 mm Hg and 24-hour hypertension was defined as mean SBP ≥130 mm Hg or mean DBP ≥80 mm Hg based on all available readings. Because the current analysis was restricted to participants with nonelevated clinic-measured BP (clinic SBP/DBP <140/90 mm Hg), participants with daytime, night-time, and 24-hour hypertension had masked daytime, masked night-time, and masked 24-hour hypertension, respectively. In addition, participants with masked daytime, night-time, or 24-hour hypertension were categorized as having any masked hypertension.
Statistical Analyses
Baseline participant characteristics were calculated for the analytic sample as mean± SD or percentages. The prevalence of any masked hypertension and masked daytime, night-time and 24-hour hypertension was calculated. The percentage of participants developing hypertension was calculated by quartile of mean daytime, night-time, and 24-hour SBP. Because we do not know the exact date participants developed hypertension, only that it developed between 2 study visits, interval-censored Cox regression 24 was used to calculate hazard ratios for incident hypertension associated with higher quartiles (quartiles 2, 3, and 4) versus lowest quartile (quartile 1) of mean daytime, nighttime, and separately, 24-hour SBP. Three models with progressive adjustment were estimated. Models adjusted for age and sex (model 1), variables in the Framingham hypertension risk prediction score, 25 including age, sex, body mass index, clinic SBP, parental history of hypertension, smoking status, age by clinic DBP interaction (model 2). A final model included additional adjustment for diabetes mellitus, education level less than high school, alcohol consumption, total physical activity score, and reduced estimated glomerular filtration rate (model 3). The above analyses were repeated for higher quartiles (quartiles 2, 3, and 4) versus the lowest quartile (quartile 1) of mean daytime, night-time, and 24-hour DBP. Hazard ratios for incident hypertension associated with SD higher mean daytime, night-time, and 24-hour SBP and DBP were also calculated. The percentage of participants developing hypertension was calculated for those with and without any masked hypertension, and masked daytime, nighttime, and 24-hour hypertension. Hazard ratios for incident hypertension associated with any masked hypertension, and masked daytime, night-time, and 24-hour hypertension were calculated with adjustment for covariates in 3 models as described above.
Because previous studies have demonstrated that prehypertension is associated with a higher risk for incident hypertension compared by guest on January 17, 2018 http://hyper.ahajournals.org/ Downloaded from with normal clinic BP, [26] [27] [28] [29] and that an overlap exists between masked hypertension and prehypertension, 4, 30 secondary analyses were performed after stratifying the sample into participants with prehypertension or normal clinic BP at baseline. Prehypertension was defined as mean clinic SBP 120 to 139 mm Hg or mean clinic DBP 80 to 89 mm Hg. Normal clinic BP was defined as mean clinic SBP <120 mm Hg and mean clinic DBP <80 mm Hg. Analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC) and Stata version 13.1 (Stata Inc, College Station, TX).
Results
Baseline Characteristics
The mean±SD age of participants included in the current analysis was 54.8±11.1 years and 69.1% were female (Table  S1 ). The prevalence of prehypertension was 57.1%. The prevalence of masked daytime hypertension, masked night-time hypertension, and masked 24-hour hypertension were 22.3%, 42.3%, and 28.7%, respectively. Overall, 45.4% of participants had any masked hypertension. Compared with JHS participants who were not included in the analyses, those who were included were older, more likely to be female, had higher high-density lipoprotein cholesterol, had a higher LVMI, were more likely to have LVH, were less likely to be a current smoker, and had higher clinic SBP and lower clinic DBP.
Ambulatory BP and Incident Clinic Hypertension
The median time between visit 1 and visit 2 and visit 1 and visit 3 was 5.0 and 8.1 years, respectively. During follow-up, there were 187 cases (59.0%) of incident clinic hypertension, 124 cases at visit 2, and an additional 63 cases at visit 3. Of the 187 cases of incident hypertension, 44 (23.5%) had incident hypertension based on having clinic SBP ≥140 mm Hg or clinic DBP ≥90 mm Hg without taking antihypertensive medication and 120 (64.2%) had incident hypertension based on taking antihypertensive medication without having either clinic SBP ≥140 mm Hg or clinic DBP ≥90 mm Hg at a follow-up visit. Finally, 23 (12.3%) had incident hypertension based on having clinic SBP ≥140 mm Hg or clinic DBP ≥90 mm Hg at a follow-up visit and were also taking antihypertensive medication.
After adjustment for age and sex, higher quartiles of daytime, night-time, and 24-hour SBP were associated with an increased risk of incident hypertension (model 1, Table 1 ). These associations remained present after further multivariable adjustment. Higher quartiles of daytime, night-time, and 24-hour DBP were also associated with an increased risk of incident clinic hypertension before and after multivariable adjustment (Table S2 ). When modeled as continuous variables, higher daytime, night-time, and 24-hour SBP and (Table S3) .
Masked Hypertension and Incident Clinic Hypertension
Overall, 79.2% and 42.2% of participants with and without any masked hypertension developed incident clinic hypertension during follow-up ( Figure) . The proportion of participants developing incident clinic hypertension was higher among participants with versus without masked daytime hypertension (85.7% versus 50.4%), masked night-time hypertension (79.9% versus 43.7%), and masked 24-hour hypertension (85.7% versus 48.2%). After multivariable adjustment, any masked hypertension and masked daytime, night-time, and 24-hour hypertension were each associated with an increased risk of incident clinic hypertension ( Table 2) .
Masked Hypertension and the Risk of Incident Clinic Hypertension Stratified by Prehypertension Status
Higher daytime, night-time, and 24-hour SBP and DBP were each associated with an increased risk of clinic hypertension among participants with prehypertension (Table S4 ). Among individuals with normal clinic BP, higher daytime, night-time, and 24-hour SBP were associated with an increased risk of incident clinic hypertension. Higher night-time and 24-hour DBP, but not daytime DBP, were associated with incident clinic hypertension in participants with normal clinic BP. Also, among participants with prehypertension, any masked hypertension, as well as each type of masked hypertension, was associated with an increased risk of clinic hypertension after multivariable adjustment (Table S5 ). Among participants with normal clinic BP, any masked hypertension and masked night-time hypertension were associated with an increased risk of incident clinic hypertension. Any masked hypertension and incident hypertension occurred among 51.9% (94/181) of participants with prehypertension and 14.7% (20/ 
Discussion
In the current population-based sample of blacks with nonelevated clinic BP at baseline, higher levels of ambulatory BP were associated with an increased risk for incident clinic hypertension. In addition, having any masked hypertension was associated with an increased risk for incident clinic hypertension as was each type of masked hypertension. Only a few studies, mostly in whites, have examined the association between masked hypertension and the development of hypertension. 7, [31] [32] [33] In an outpatient sample of 34 Spanish children and adolescents, aged 6 to 18 years, with masked daytime hypertension, Lurbe et al 31 showed that after a median followup of 37 months there were 3 participants (8.8%) who developed sustained hypertension. No participants in the control group of 200 children and adolescents with sustained normotension progressed to sustained hypertension. In the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study, which enrolled a population sample from Monza, Italy, 32 47.1% of participants with masked 24-hour hypertension developed sustained hypertension after 10 years of follow-up compared with 18.2% of those with sustained normotension. Also, in a study of 232 Canadian public insurance employees with masked daytime hypertension, sustained hypertension was present in 61 (26.3%) participants after 3 years and 81 (34.9%) participants after 5 years of follow-up. 33 In that study, the progression from sustained normotension to sustained hypertension was not reported.
An important limitation of our study is that ABPM was not performed at the follow-up visits. Therefore, this study was unable to confirm whether participants categorized as having clinic hypertension at follow-up had sustained hypertension or white coat hypertension, defined as elevated clinic BP but nonelevated ambulatory BP. However, previous studies have shown that the progression of masked hypertension to white coat hypertension is uncommon. In the PAMELA study, 32 and in a study by Trudel et al, 33 only 7.6% and 0.5%, respectively, of participants with masked hypertension at baseline had white coat hypertension during follow-up. Therefore, it is likely that most of the participants in this study with incident clinic hypertension during follow-up had sustained hypertension. This study was also unable to determine the percentage of participants with masked hypertension at baseline who continued to have masked hypertension or alternatively had sustained normotension at follow-up. In the PAMELA study, among participants with masked hypertension at baseline and who did not have elevated clinic BP at follow-up, 51.9% and 48.1% had masked hypertension and sustained normotension, respectively, during follow-up. In younger adults, clinic BP is, on average, lower than ambulatory BP. 9, 10, 34, 35 It has been proposed that during the aging process, some individuals reach a stage where their ambulatory BP exceeds the threshold for a diagnosis of hypertension, whereas their clinic BP is not yet in the hypertensive range; 9,10 many of these individuals are likely to have prehypertension. We have previously reported that there is a substantial overlap between masked hypertension and prehypertension. 30 Given that prehypertension is associated with an increased risk of incident clinic hypertension compared with normal clinic BP, 29 prehypertension may explain the increased risk for clinic hypertension among individuals with masked hypertension. However, in this study, the association between any masked hypertension and incident clinic hypertension was independent of clinic BP level, and this association was also similar for participants with prehypertension and those with normal clinic BP.
In our study, masked night-time hypertension, but not masked daytime or masked 24-hour hypertension, was associated with incident clinic hypertension among those with normal clinic BP. Previous studies have shown that compared with whites, blacks have a higher prevalence of night-time hypertension. [36] [37] [38] The underlying mechanisms linking nighttime hypertension to incident clinic hypertension in blacks are unknown. Psychosocial stress, sleep apnea as well as biological factors such as arterial stiffness, inflammation, endothelial dysfunction, and salt sensitivity may be possible mechanisms. [39] [40] [41] [42] Future studies should examine the factors linking masked night-time hypertension to incident clinic hypertension among blacks.
Given the substantial morbidity and mortality associated with hypertension, earlier identification of individuals at a high risk for developing hypertension is of paramount importance. The results of our study suggest that the identification of masked hypertension among individuals with nonelevated clinic BP using ABPM may identify those at highest risk for incident clinic hypertension. Previous studies 15, 16, 26, 43, 44 have demonstrated that lifestyle modification and pharmacological therapy may delay the onset of hypertension among high-risk individuals including those with prehypertension. These preventive strategies may prove to be most effective for not only the subset of individuals with prehypertension who have masked hypertension but also for those individuals with normal clinic BP and masked hypertension. Furthermore, in this study, 6.2% of participants had LVH at baseline. Diaz et al 4 previously demonstrated that among JHS participants, masked hypertension was associated with increased LVMI. Given the increased cardiovascular disease risk associated with LVH, 45 individuals with masked hypertension and LVH may represent a high-risk group that might benefit from antihypertensive medication initiation before the development of clinic hypertension. Randomized trials are needed to determine whether lifestyle modification and pharmacological therapy delay hypertension onset and reverse cardiovascular end-organ damage among individuals with masked hypertension.
There are several strengths of this study. We used data from a population-based sample composed entirely of blacks.
There have been few previous investigations of ABPM among *Model 1 includes adjustment for age and sex. †Model 2 includes model 1 variables plus additional adjustment for body mass index, clinic systolic blood pressure, parental history of hypertension, smoking status (never/former and current), and age by clinic diastolic blood pressure interaction. ‡Model 3 includes model 2 variables plus additional adjustment for diabetes mellitus, education level less than high school, alcohol consumption (nondrinker, moderate, and heavy), total physical activity score, and estimated glomerular filtration rate <60 mL/min per 1.73 m blacks, 4, 46 and this population has a high risk for masked hypertension 4 and incident clinic hypertension. 12 Also, given the broad data collection in the JHS, we were able to control for multiple potential confounders. We were also able to examine several types of masked hypertension including masked daytime, night-time, and 24-hour hypertension, as well as determine the risk of incident clinic hypertension stratified by prehypertension status. In addition to ABPM not being conducted at a follow-up visit in the JHS, there were also other possible limitations. Only a subsample of JHS participants had ABPM performed at the baseline visit. Information about napping during the daytime period and awakening during the night-time period, which may affect estimates of daytime and night-time BP, was not collected. In addition, the JHS did not conduct home BP monitoring, another out-of-clinic approach for measuring BP, which also can be used to determine masked hypertension. Some evidence suggests that many individuals have masked hypertension on either ABPM or home BP monitoring, but not on both. 47 Therefore, masked hypertension on ABPM versus home BP monitoring may represent different out-of-clinic BP phenotypes. We were unable to assess the association of masked hypertension on home BP monitoring and incident hypertension within the JHS.
Perspectives
Among blacks with nonelevated clinic BP and who were not taking antihypertensive medication, masked hypertension was associated with an increased risk for the development of clinic hypertension. The association between any masked hypertension and incident clinic hypertension was present after adjustment for clinic BP, and was similar among participants with prehypertension and normal clinic BP. Also, daytime, night-time, and 24-hour masked hypertension was each associated with incident clinic hypertension. The results of this study suggest that among black adults with nonelevated clinic BP, ABPM can identify those who are at increased risk for developing clinic hypertension.
What Is New?
• We examined the associations of masked hypertension and its subtypes (masked daytime, night-time, and 24-hour hypertension) with incident clinic hypertension among a population-based cohort of blacks.
• We also evaluated whether these associations were independent of clinic blood pressure level and consistent for those with prehypertension and separately, normal clinic blood pressure.
What Is Relevant?
• It has been hypothesized that masked hypertension represents an intermediate phenotype between normotension and hypertension.
• Few population-based studies have examined the association between masked hypertension and incident hypertension, and none have examined this association in blacks, who have a high prevalence of masked hypertension.
Summary
Among a large population-based cohort study of blacks with nonelevated clinic blood pressure, participants with any masked hypertension had twice the risk of incident clinic hypertension compared with participants without masked hypertension during an 8-year follow-up period. Among participants with either prehypertension or normal clinic blood pressure, masked hypertension was associated with increased risk of incident clinic hypertension.
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Supplemental Methods
Data Collection & Clinical Covariates
During the in-home interview, trained African American interviewers administered standardized questionnaires to collect self-reported information on socio-demographics (e.g. age, sex, education, marital status, and socioeconomic status), prior diagnosed comorbid conditions, parental history of hypertension, and selected health behaviors (e.g. alcohol consumption, current smoking, and physical activity). 1 Education was measured as the highest level of schooling completed and classified into two categories within this study as "less than high school" or "greater than high school". Physical activity over the past 12 months was assessed using the JHS Physical Activity Cohort (JPAC) survey, a 30-item validated questionnaire. 2, 3 The JPAC has four index scores that correspond to four physical activity domains (active living, work, sport, and home/life). The total physical activity score was calculated as the sum of the four index scores, with work scores set to 0 for participants who reported no paid or volunteer work during the past year. Higher scores represent more daily physical activity. Current smoking was defined by affirmative responses to the questions "Have you smoked more than 400 cigarettes in your lifetime?" and "Do you now smoke cigarettes?" Daily alcohol consumption was assessed from a validated food frequency questionnaire 4 and in our study defined as "none": 0 drinks/week, "moderate" consumption: 1-14 and 1-7 alcoholic drinks/week for men and women respectively, and "heavy" consumption: >14 and >7 alcoholic drinks/week for men and women respectively. 5 Parental history of hypertension was defined by affirmative responses to the questions "Did your mother ever have (or does she have) high blood pressure or hypertension?" and/or "Did your father ever have (or does he have) high blood pressure or hypertension?"
Participants were asked to bring any medications taken within 2 weeks prior to the baseline examination to the clinic visit and were transcribed verbatim. Medication coding was performed by a pharmacist using the Medispan dictionary and classified into categories according to the Therapeutic Classification System. Antihypertensive medication use was defined by self-report. Participants were asked to avoid caffeine, eating, heavy physical activity, smoking, and alcohol intake for 12 hours prior to the clinic examination. During the clinical examination, weight and height were measured for each participant. Body mass index was calculated as the weight in kilograms divided by height in meters squared (kg/m 2 ). Fasting blood samples were collected according to standardized procedures 6 and processed at two central laboratories (University of Mississippi Medical Center and the University of Minnesota). 6 Total and high-density lipoprotein (HDL) cholesterol was quantified by an oxidase method and low-density lipoprotein (LDL) cholesterol was calculated using the Freidewald equation. 6 Estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. 7 Reduced eGFR was defined as <60 ml/min/1.73 m 2 . Diabetes was defined as a fasting (≥8 hours) serum glucose ≥126 mg/dL or hemoglobin A1c ≥6.5% or use of insulin or oral hypoglycemic medications within 2 weeks prior to the clinic examination.
Echocardiography
Two-dimensional echocardiography (Sonos-4500, Philips Medical Systems, Andover, MA) was used for assessment of left ventricular (LV) dimensions including LV internal diameter during diastole (LVIDd), interventricular septal thickness during diastole (IVSd), and posterior wall thickness during diastole (PWTd), according to previously described protocols based on the recommendations of the American Society of Echocardiography (ASE). 8 Left ventricular mass (LVM, grams) was also derived according to ASE recommendations. 8 LVM index (LVMI, g/m 2 ) was calculated as LVM/body surface area. Left ventricular hypertrophy (LVH) was defined as LVMI ≥ 96 g/m 2 in females and LVMI ≥ 116 g/m 2 in males. 8
Blood Pressure Comparability Study
As the Jackson Heart Study (JHS) began transitioning from using a random-zero sphygmomanometer (RZS) to an Omron HEM-907XL (Omron Healthcare Inc., Lake Forest, Il. At Visit 2, two technicians measured each participant's blood pressure (BP) simultaneously with the RZS and AOD using a Y connector and a double-headed stethoscope. Each technician was blinded to the other's readings. The RZS was used to determine the pulse obliteration pressure using the standard RZS equipment. Next, the technician replaced the RZS cuff with the AOD cuff. The AOD was set to manual mode and used to inflate and deflate the BP cuff; the maximum value corresponding to the RZS in use was used to determine the peak inflation value for the AOD. During the deflation period, both technicians listened for the onset of the 1 st and 5 th Korotkoff phase sounds and recorded the corresponding systolic and diastolic BP. This was repeated twice per participant; thus, participants had a total of four BP readings: two from the RZS and two from the AOD. For analysis purposes, we averaged the two devicespecific measurements.
Once exploratory data analysis began, the JHS CC discovered a large amount of noise in the data; Figures S1 and S2 show the observed noise for systolic BP and diastolic BP, respectively. The level of noise observed in the JHS data is not unexpected and has been shown elsewhere in the literature. [9] [10] [11] However, due to such noise, the JHS CC decided to investigate several calibration methods beyond normal ordinary least squared (OLS) regression. The following 5 methods were explored:
1. Ignoring the change. This method completely ignores that the JHS changed blood pressure machines. If an AOD measure is present at clinic exam Visit 2, its value is used. Otherwise, the RZS measure is used.
Ordinary least squares.
This method predicts a participant's AOD measure by creating a prediction equation using ordinary OLS regression, where the participant's RZS measure is the only predictor. 3. Deming regression. Considered the gold standard for calibration techniques, this method is similar to OLS but is an errors-in-variables regression model that accounts for error both in the dependent and independent variables. 12 4. Adjustment via average difference. Rather than adjust using a prediction equation, this method adjusts all participants by the observed average difference between the AOD and the RZS. 5. Modeling the difference between AOD and RZS as a function of RZS. This method utilizes the difference between AOD and RZS measurements as the outcome and the participant's RZS measure as the predictor; that is, this models the difference between machines as a function of the participant's RZS measure.
Rather than normal OLS methods, this prediction model is created using robust regression. 13 Several example models were compared across the different calibration methods. In particular, the JHS CC examined the resulting regression coefficients and standard errors; results across calibration methods were similar. Based on the shape of the data, the JHS CC felt most comfortable calibrating the data using a function of the RZS measurement. Thus, the JHS CC recommended that JHS researchers use the calibration equation created by method 5 (modeling the difference between AOD and RZS as a function of RZS). The following equations resulted from method 5 and were used to predict SBP and DBP for the current study: For the current study, a sensitivity analysis using method 1 (ignoring the change) was performed. Using this method, the study results were unchanged -the associations of daytime blood pressure, night-time blood pressure, 24-hour blood pressure (for both systolic and diastolic), any masked hypertension, masked daytime hypertension, masked night-time hypertension, and masked 24-hour hypertension with incident clinic hypertension were similar. n/a n/a Masked night-time hypertension, % 42.3% n/a n/a Masked 24-hour hypertension, % 28.7% n/a n/a Any masked hypertension, % 45.4% n/a n/a *Numbers in the table are percentages or mean ± standard deviation. † Left ventricular hypertrophy was defined as left ventricular mass index ≥ 96 g/m 2 in females and as ≥ 116 g/m 2 in males. ‡ Prehypertension is defined as mean clinic systolic blood pressure 120-139 mm Hg or mean clinic diastolic blood pressure 80-89 mm Hg. § Normal clinic blood pressure is defined as mean clinic systolic blood pressure < 120 mm Hg and mean clinic diastolic blood pressure < 80 mm Hg. Masked daytime hypertension is defined as mean daytime systolic blood pressure ≥ 135 mm Hg or mean daytime diastolic blood pressure ≥ 85 mm Hg. Masked night-time hypertension is defined as mean night-time systolic blood pressure ≥ 120 mm Hg or mean night-time diastolic blood pressure ≥ 70 mm Hg. Masked 24-hour hypertension is defined as mean 24-hour systolic blood pressure ≥ 130 mm Hg or mean 24-hour diastolic blood pressure ≥ 80 mm Hg. Any masked hypertension is defined as having masked daytime hypertension, masked night-time hypertension or masked 24-hour hypertension. n/a=not applicable Model 2 includes Model 1 variables plus additional adjustment for body mass index, clinic systolic blood pressure, parental history of hypertension, smoking status (never/former, current), age by clinic diastolic blood pressure interaction. Model 3 includes Model 2 variables plus additional adjustment for diabetes, education level less than high school, alcohol consumption (non-drinker, moderate, heavy), total physical activity score, and estimated glomerular filtration rate < 60 ml/min/1.73m 2 . Model 2 includes Model 1 variables plus additional adjustment for body mass index, clinic systolic blood pressure, parental history of hypertension, smoking status (never/former, current), age by clinic diastolic blood pressure interaction. Model 3 includes Model 2 variables plus additional adjustment for diabetes, education level less than high school, alcohol consumption (non-drinker, moderate, heavy), total physical activity score, and estimated glomerular filtration rate < 60 ml/min/1.73m 2 . Table S4 . Hazard ratios for incident clinic hypertension associated with each standard deviation higher daytime, nighttime, and 24-hour systolic and diastolic blood pressure on ambulatory blood pressure monitoring among Jackson Heart Study participants with prehypertension and normal clinic blood pressure, separately. Model 2 includes Model 1 variables plus additional adjustment for body mass index, clinic systolic blood pressure, parental history of hypertension, smoking status (never/former, current), age by clinic diastolic blood pressure interaction. Model 3 includes Model 2 variables plus additional adjustment for diabetes, education level less than high school, alcohol consumption (non-drinker, moderate, heavy), total physical activity score, and estimated glomerular filtration rate < 60 ml/min/1.73m 2 . * Prehypertension is defined as mean clinic systolic blood pressure 120-139 mm Hg or mean clinic diastolic blood pressure 80-89 mm Hg. Table S5 . Hazard ratios for incident clinic hypertension associated with any masked hypertension, masked daytime hypertension, masked night-time hypertension, and masked 24-hour hypertension among Jackson Heart Study participants with prehypertension and normal clinic blood pressure, separately.
Among participants with prehypertension*
Type of Masked Hypertension
Hazard ratio (95% confidence interval) 
Any masked hypertension
